IT-Analysis.com
IT-Analysis.com Logo
Business Issues Security & Risk
Business Issues Channels Enterprise Services SME Technology
Module Header
Louella FernandesLouella Fernandes
Louella Fernandes
11th April - Managed Print Services: Are SMBs Ready?
Louella FernandesLouella Fernandes
Louella Fernandes
11th April - The Managed Print Services (MPS) Opportunity for SMBs
Simon HollowayThe Holloway Angle
Simon Holloway
11th April - Intellinote - capture anything!
David NorfolkThe Norfolk Punt
David Norfolk
11th April - On the road to Morocco
Philip HowardBloor IM Blog
Philip Howard
10th April - Attunity Gold Client

News Release

IGEL integrates Imprivata OneSign ProveID Embedded into thin clients
Released: 28th August 2013
Publisher: RealWire

Reading, UK August 28, 2013 – IGEL Technology today announced its thin clients will support Imprivata OneSign ProveID Embedded, a new solution designed to provide healthcare workers with secure, No Click Access® to clinical applications within Virtual Desktop Environments (VDI).  Incorporated into IGEL’s thin client firmware, Imprivata OneSign ProveID Embedded provides customers with an out-of-the-box solution for delivering seamless access to clinical applications and patient information at the point of care. Imprivata OneSign ProveID Embedded will initially be integrated with the IGEL UD2-LX MultiMedia Universal Desktop thin client, and through support for Intel x86 processor architecture, future versions of Imprivata OneSign ProveID Embedded will integrate with IGEL’s wider range of thin client devices.

Initially developed in collaboration with Texas Instruments, the Imprivata OneSign ProveID Embedded architecture enables Imprivata OneSign authentication workflows to be directly integrated into thin devices, providing customers with an out-of-the-box solution for giving clinicians fast, secure access to applications and information from any endpoint. By eliminating the need to remember and enter multiple passwords to access virtual desktops, Imprivata OneSign ProveID Embedded improves workflow efficiency and enables providers to better focus on patient care.

The self-updating Imprivata OneSign ProveID Embedded automatically checks for an Imprivata OneSign infrastructure and downloads the latest agent. It also automatically detects, downloads and installs any updated agents on the endpoint device without any input from IT or the end user and without the need to reboot. This minimizes cost and maintenance requirements while helping organizations optimize their virtual desktop environments.

“IGEL is committed to developing thin clients with an open, flexible architecture that help customers maximize the efficiency of their virtual desktop infrastructure by enabling integration with applications that best fit their workflow requirements,” said Dr Frank Lampe, Marketing Director, at IGEL Technology.   “Integrating Imprivata OneSign ProveID Embedded into the firmware of IGEL’s thin clients supports this approach, and offering out-of-the-box strong authentication capabilities allows users to quickly, simply and securely access their roaming sessions.”

“Strong authentication allows healthcare organizations to optimize their virtual desktop environments by allowing clinicians to quickly and seamlessly access the information they need, wherever they need it to deliver the highest-quality patient care possible,” said David Ting, founder and Chief Technology Officer at Imprivata, a leading global provider of healthcare IT security solutions. “Imprivata OneSign ProveID Embedded enhances these benefits by enabling IGEL to deliver off-the-shelf strong authentication capabilities integrated directly into its thin clients, which further simplifies access to roaming desktops for clinicians while ensuring that HIPAA compliance and security requirements are satisfied.”

Further Information

RealWire
Samantha Sharp
Service Delivery Executive
Tel: +44 (0)1522 883640
Email: enquires@realwire.com


Related Links:

Advertisement



Published by: IT Analysis Communications Ltd.
T: +44 (0)190 888 0760 | F: +44 (0)190 888 0761
Email: